Found 7 matching trials
Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions
PHASE1It is an open-label, balanced, randomized, five-treatment, five-period, fiv...
Location
Lambda Therapeutic Research Ltd.
A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions
PHASE1An open label, balanced, randomized, two-treatment, two-period, two-sequenc...
Location
Multiple Locations
A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease
PHASE2It is a phase II randomized, parallel, double-blind, placebo-controlled, mu...
Location
Shanghai Huashan Hospital
PK Study of WD-1603 in Healthy Subjects
PHASE1An open label, balanced, randomised, four-treatment, four-period, four-sequ...
Location
Lambda Therapeutic Research Ltd.
WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects
PHASE1The Phase 1 PK study is planned to evaluate the food effect on WD-1603 phar...
Location
Lambda Therapeutic Research Ltd.
A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants
PHASE1WD-1603 contains two different drugs called levodopa and carbidopa in one t...
Location
Shanghai Xuhui Central Hospital
WD-1603 PK Study in Healthy Volunteers
PHASE1This is a pilot study to investigate if the extended release formulation of...
Location
INC Research Toronto, Inc.